Fatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors
Key claim: Investigators hypothesize that cancer survivors have higher circulating fatty acid binding proteins and cellular senescence markers than people who never had cancer, potentially correlating with treatment exposures and later metabolic disease risk.
Abstract
The purpose of this research study is to investigate whether cancer survivors have higher levels of proteins called Fatty Acid Binding Proteins as well as 12 different markers of cellular senescence than people who have never had cancer. Investigators believe that these levels may be elevated in cancer survivors as a result of their cancer and the treatments they received and may put them at higher risk for chronic conditions such as high cholesterol, diabetes, high blood pressure, and obesity. This study will also compare the levels of these proteins and inflammatory markers in the blood with different aspects of cancer treatment the survivors received. Investigators are investigating if there is a correlation between levels of these proteins and markers, the type of treatment cancer survivors received, and development of metabolic conditions.
Why this matters
Investigators hypothesize that cancer survivors have higher circulating fatty acid binding proteins and cellular senescence markers than people who never had cancer, potentially correlating with treatment exposures and later metabolic disease risk.